Menopause
MS does not worsen menopause symptoms, study finds

Menopause is not linked to increased disability accumulation in women with multiple sclerosis, according to the largest study to date.
The study followed 987 Australian women with MS over 14 years, of whom 404 (40 per cent) had gone through menopause, and found no link between hormonal changes and disease progression.
Led by Monash University and published in JAMA Neurology, the research analysed data from the MSBase Registry, the world’s largest MS outcomes register, which tracks more than 120,000 people worldwide.
Associate Professor Vilija Jokubaitisis deputy head of Monash University’s School of Translational Medicine Department of Neuroscience
The researcher said: “MS disability typically gets worse in both men and women as people age, with a noticeable shift at about the age of 50, which is also around the age of menopause for most women.
“During perimenopause, the amount of oestrogen and progesterone in women fluctuates a lot, before levels of these hormones fall significantly at menopause.
“In this study we asked whether the loss of sex hormones at menopause could be the reason for MS worsening in women at midlife.”
Participants were recruited from eight Australian neuroimmunology-specialist centres.
Earlier, smaller studies of between 74 and 148 post-menopausal women had produced mixed results about the role of sex hormones in MS progression.
The study found that while disability increases with age, menopause itself is not a direct cause, with other ageing processes likely responsible.
“Whilst reproductive ageing may be additive to the effects of somatic ageing, our study does not support menopause as the leading factor for disability progression in older women with MS,” the researchers concluded.
Dr Francesca Bridge, neurologist at Alfred Health and the study’s first author, said the findings should reassure women with MS.
“The menopausal transition can be challenging for many women,” Dr Bridge said.
“This study gives women with MS one less thing to be concerned about. This study will guide the health/clinical management of women with MS through the menopausal transition.”
She added that menopausal symptoms such as hot flushes, memory problems, mood changes and urinary dysfunction could overlap with MS symptoms.
“Women with MS will benefit from the holistic management of menopausal symptoms with lifestyle measures such as exercise and maintaining a healthy diet, as well as pharmacological measures such as menopausal hormone therapy (MHT) and non-hormone-based medications to improve their symptoms and quality of life,” she said.
The results are expected to shape clinical discussions about managing menopause in women with MS, including lifestyle adjustments and the use of hormone therapy where appropriate.
Menopause2 weeks agoPerimenopause misinformation ‘putting women at risk’
Hormonal health2 weeks agoNHS urged to update website following renaming of PCOS
Insight3 weeks agoPCOS renamed after decade-long campaign to end ‘cyst’ misconception
Adolescent health4 weeks agoWUKA brings Period-Positive Pool Party to London Aquatics Centre to keep girls swimming through puberty
Menopause4 weeks agoCBT shows promise for menopause insomnia and hot flashes
Entrepreneur1 week agoWomen’s Health Innovation Summit opens submissions for 2026 Innovation Showcase
Menopause1 week agoWomen still being failed when they reach menopause, experts say
Diagnosis4 weeks agoArtera receives FDA Clearance for breast cancer platform
















